TABLE 1.

Clinical features of Epstein-Barr virus (EBV) Syndrome in orthotopic liver transplant recipients

Case no.	Age (yr)/sex	Primary disease	Period of onset of EBV syndrome following transplant (days)	Presenting clinical features	Outcome of initial EBV syndrome	Recurrent EBV syndromes	Final outcome of EBV infection
1	53/M	CC	63	Fever, pharyngitis, cervical and axillary LN	Resolution over 5 wk	PTLD lung and ileum resolved over 8 wk	Resolution
2	22/M	PSC	43	Fever, pharyngitis generalized LN, Sp, icterus	Resolution over 8 wk	NIL	Resolution
3	44/F	CC	14	Fever, generalized LN, icterus	Resolution over 8 wk	NIL	Resolution
4	28/F	CC	27	Arthralgia right knee, petechial rash	Resolution over 2 wk	Systemic PTLD, fatal over 1 mo	Death
5	20/M	CC	603	Fever, pharyngitis, paratracheal LN, diarrhea, jaw pains, arthralgias, right pleural effusion, Sp	Developed systemic PTLD, death at 8 wk		Death
6	58/M	Alcoholic cirrhosis	31	Fever, cervical and axillary LN	Resolution over 2 wk	Meningoencephalitis resolving over 5 days	Resolution
7	26/F	α-1ATD	74	Icterus, axillary LN	Resolution over 3 wk	Systemic PTLD responsive to immunomodulation	Resolution
8	18/F	Wilson’s	10	Fever, sinus headaches generalized LN	Resolution over 3 wk	NIL	Resolution
9	54/M	CAH-B hepatoma	36	Fever, generalized LN	Developed systemic PTLD, fatal over 2 wk	Not applicable	Death
10	42/F	CAH cirrhosis	623	Fever, pharyngitis, generalized LN, Sp, ascites, dysarthria, dysmetria, pneumonitis	Resolved over 11 wk	NIL	Resolution

CC, cryptogenic cirrhosis; PSC, primary sclerosing cholangitis; CAH, chronic active hepatitis; α-1ATD, α-1antitrypsin deficiency; LN, lymphadenitis; Sp, splenomegaly; PTLD, posttransplant lymphoproliferative disorders.